ArticleGeroScience2022

Investigating the combination of plasma amyloid-beta and geroscience biomarkers on the incidence of clinically meaningful cognitive decline in older adults.

Wan-Hsuan Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.